IRIS
DE VITA, Ferdinando
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 16.057
NA - Nord America 8.377
AS - Asia 6.614
SA - Sud America 1.049
Continente sconosciuto - Info sul continente non disponibili 603
AF - Africa 91
OC - Oceania 11
Totale 32.802
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 9.985
US - Stati Uniti d'America 8.131
SG - Singapore 2.295
IE - Irlanda 1.734
CN - Cina 1.425
HK - Hong Kong 1.020
IT - Italia 953
BR - Brasile 873
VN - Vietnam 778
UA - Ucraina 763
GB - Regno Unito 678
DE - Germania 617
FR - Francia 406
KR - Corea 388
FI - Finlandia 321
SE - Svezia 214
IN - India 174
CA - Canada 168
TR - Turchia 147
GR - Grecia 137
JP - Giappone 136
AR - Argentina 58
BD - Bangladesh 47
NL - Olanda 47
AT - Austria 46
MX - Messico 42
PL - Polonia 42
ID - Indonesia 39
BE - Belgio 33
EC - Ecuador 29
IQ - Iraq 27
ES - Italia 22
ZA - Sudafrica 22
PK - Pakistan 20
CL - Cile 18
VE - Venezuela 18
CO - Colombia 15
MA - Marocco 14
PE - Perù 14
SC - Seychelles 13
CZ - Repubblica Ceca 11
AL - Albania 10
PH - Filippine 10
SA - Arabia Saudita 10
IL - Israele 9
PY - Paraguay 9
TH - Thailandia 9
UZ - Uzbekistan 9
AE - Emirati Arabi Uniti 8
BO - Bolivia 7
DO - Repubblica Dominicana 7
KZ - Kazakistan 7
NP - Nepal 7
PT - Portogallo 7
TN - Tunisia 7
UY - Uruguay 7
AZ - Azerbaigian 6
EG - Egitto 6
IR - Iran 6
KE - Kenya 6
NZ - Nuova Zelanda 6
AU - Australia 5
EU - Europa 5
JM - Giamaica 5
JO - Giordania 5
LB - Libano 5
LT - Lituania 5
MY - Malesia 5
SN - Senegal 5
CR - Costa Rica 4
HN - Honduras 4
CG - Congo 3
ET - Etiopia 3
KG - Kirghizistan 3
LU - Lussemburgo 3
LV - Lettonia 3
RS - Serbia 3
SV - El Salvador 3
TW - Taiwan 3
AO - Angola 2
BG - Bulgaria 2
BH - Bahrain 2
BY - Bielorussia 2
CY - Cipro 2
DZ - Algeria 2
GT - Guatemala 2
HU - Ungheria 2
LK - Sri Lanka 2
MK - Macedonia 2
OM - Oman 2
PA - Panama 2
PR - Porto Rico 2
QA - Qatar 2
RO - Romania 2
UG - Uganda 2
XK - ???statistics.table.value.countryCode.XK??? 2
AG - Antigua e Barbuda 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
Totale 32.183
Salva come PNG Salva come JPEG
Città #
Moscow 3.641
Dublin 1.726
Jacksonville 1.178
San Jose 1.034
Hong Kong 1.012
Santa Clara 997
Singapore 923
Chandler 805
Ashburn 395
Seoul 372
Princeton 244
Ho Chi Minh City 239
Medford 216
New York 194
Hanoi 186
Beijing 170
Hefei 168
Naples 152
Caserta 143
Ann Arbor 142
Roxbury 141
Boardman 140
Bremen 134
Council Bluffs 125
San Mateo 125
Bengaluru 122
Helsinki 116
Munich 100
Elora 97
Wilmington 97
Dallas 88
Los Angeles 88
Woodbridge 75
São Paulo 69
The Dalles 66
Nanjing 65
Des Moines 53
Dong Ket 52
Cambridge 51
Nuremberg 49
Napoli 46
Milan 43
Jinan 37
Rome 37
Da Nang 36
Chicago 31
Mountain View 30
Rio de Janeiro 30
Haiphong 27
Amsterdam 26
Kraków 26
Brussels 25
Houston 24
Tianjin 24
Tokyo 24
Belo Horizonte 23
Vienna 23
Orem 22
Atlanta 21
Curitiba 20
Memphis 19
Norwalk 19
Toronto 19
Aversa 18
Hangzhou 18
Turku 18
Zhengzhou 18
Biên Hòa 17
Shanghai 17
Changsha 16
Düsseldorf 16
Shenyang 16
Brasília 15
Chennai 15
Guangzhou 15
Jakarta 15
Aiello Del Sabato 14
Hải Dương 14
Montreal 14
London 13
Nanchang 13
San Francisco 13
Thái Nguyên 13
Auburn Hills 12
Brooklyn 12
Ottawa 12
Phoenix 12
Thái Bình 12
Frankfurt am Main 11
Guarulhos 11
Hillsboro 11
Istanbul 11
Lanzhou 11
Manchester 11
Porto Alegre 11
Taizhou 11
Brno 10
Ercolano 10
Guayaquil 10
Lima 10
Totale 16.918
Salva come PNG Salva come JPEG
Nome #
Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma and Child-Pugh A or B cirrhosis 211
Anti-epidermal growth factor receptor monoclonal antibodies in cancer therapy. 209
ONCOLOGIA MEDICA 209
MicroRNA-423-5p promotes autophagy in cancer cells and is increased in serum from hepatocarcinoma patients treated with sorafenib 195
A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients 195
Expression of c-MET in Estrogen Receptor Positive and HER2 Negative Resected Breast Cancer Correlated with a Poor Prognosis 188
Effect of preoperative chemoradiotherapy on outcome of patients with locally advanced esophagogastric junction adenocarcinoma—a pilot study. Curr Oncol 21, 3, june 2014 125-133 188
Small bowel metastasis from pancreatic cancer in a long-term survival patient with synchronous advanced malignant pleural mesothelioma: A case report and literature review 187
Adjuvant chemoradiotherapy in patients with stage III-IV radically resected gastric cancer: a pilot study 186
Comprehensive genome profiling by next generation sequencing of circulating tumor DNA in solid tumors: a single academic institution experience 185
A case report of a severe fluoropyrimidine-related toxicity due to an uncommon DPYD variant 184
A multicenter phase II study of induction chemotherapy with FOLFOX-4 and cetuximab followed by radiation and cetuximab in locally advanced oesophageal cancer 181
Modified versus standard D2 lymphadenectomy in total gastrectomy for nonjunctional gastric carcinoma with lymph node metastasis 179
A possible connective tissue primary lymphoepithelioma-like carcinoma (LELC). 179
Antitumor activity of bortezomib in human cancer cells with acquired resistance to anti-epidermal growth factor receptor tyrosine kinase inhibitors 178
Neutrophil to lymphocyte ratio (NLR) for prediction of distant metastasis-free survival (DMFS) in early breast cancer: A propensity score-matched analysis 178
Microsatellite Status Detection in Gastrointestinal Cancers: PCR/NGS Is Mandatory in Negative/Patchy MMR Immunohistochemistry 176
Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study) 175
Comparison of the current AJCC-TNM numeric-based with a new anatomical location-based lymph node staging system for gastric cancer: A western experience 174
CD 26-positive/CD 326-negative circulating cancer cells as prognostic markers for colorectal cancer recurrence 173
Amifostine: a selective cytoprotective agent of normal tissues from chemo-radiotherapy induced toxicity (Review) 172
Analysis of neurothelin expression in neoplastic cells derived from gastrointestinal tract tumors 171
A true splenic cyst producing carboydrate antigen 19-9 and cancer antigen 50 and 125,but not interleukin 10 170
Clinical management of advanced gastric cancer: Role of new molecular drugs. 170
Antitumor activity of sorafenib in human cancer cell lines with acquired resistance to EGFR and VEGFR tyrosine kinase inhibitors. 168
Elevated perioperative serum vascular endothelial growth factor levels in patients with colon carcinoma. 166
Different Biomarkers address different colorectal cancer stem cell populations: who's the killer? 166
Antitumor activity of ZD6474, a vascular endothelial growth factor-2 and epidermal growth factor receptor small molecule tyrosine kinase inhibitor, in combination with SC-236, a cyclooxygenase-2 inhibitor 164
Liquid Biopsy at Home: Delivering Precision Medicine for Patients with Cancer During the Covid-19 Pandemic 164
Combined CD133/CD44 Expression as a Prognostic Indicator of Disease-Free Survival in Patients With Colorectal Cancer. 163
Naples Prognostic Score Predicts Tumor Regression Grade in Resectable Gastric Cancer Treated with Preoperative Chemotherapy 163
Clinical outcome and molecular characterisation of chemorefractory metastatic colorectal cancer patients with long-term efficacy of regorafenib treatment 162
Behavior of circulating CD4+CD25+FOXP3* regulatory T cells in colon cancer patients undergoing surgery 162
Activity and molecular targets of pioglitazone via blockade of proliferation, invasiveness and bioenergetics in human NSCLC 162
Pancreatic fistula following pancreatoduodenectomy. Evaluation of different surgical approaches in the management of pancreatic stump. Literature review. 159
A true splenic cyst producing carbohydrate antigen 19-9 and cancer antigens 50 and 125, but not interleukin 10 159
Behaviour of interleukin-2 serum levels in advanced non-small-cell lung cancer patients: relationship with response to therapy and survival 158
Treatment of gastric cancer. 157
Cetuximab, a chimeric human mouse anti-epidermal growth factor receptor monoclonal antibody, in the treatment of human colorectal cancer 155
Conversion chemotherapy followed by epatic resection in colorectal cancer with initially unresectable liver-limited metastases 155
Predictive biomarkers along gastric cancer pathogenetic pathways 155
antitumor activity of zd6474, a VEGFR-2 and EGFR small molecule tyrosine kinase inhibitor in combination with SC-236, a cicloxigenase-2 inhibitor 154
Conservative management and parenchyma-sparing resections of pancreatic neuroendocrine tumors: Literature review. 153
Analysis of interleukin-2/interleukin-2 receptor system in advanced non-small-cell lung cancer 151
An intramedullary "flame" recognized as being an intramedullary spinal cord metastasis from esophageal cancer 151
Circulating levels of interleukin-10 and interleukin-6 in gastric and colon cancer patients before and after surgery: relationship with radicality and outcome 150
Inflammatory and nutritional status is a predictor of long-term outcome in patients undergoing surgery for gastric cancer. Validation of the Naples prognostic score. 150
Antitumor activity of ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to antiepidermal growth factor receptor therapy 149
Adult Wilms' tumor: a case report 149
DNA-PK inhibition sustains the antitumor innate immune response in small cell lung cancer 148
Serum insulin-like growth factor 1 correlates with the risk of nodal metastasis in endocrine-positive breast cancer 148
Novel Therapeutic Opportunities in Neoadjuvant Setting in Urothelial Cancers: A New Horizon Opened by Molecular Classification and Immune Checkpoint Inhibitors 148
Neutrophil to lymphocyte ratio is a strong predictor of tumor recurrence in early colon cancers: a propensity score-matched analysis 147
Clinical practice use of liquid biopsy to identify RAS/BRAF mutations in patients with metastatic colorectal cancer (mCRC): A single institution experience 147
Correlation between efficacy and skin rash occurrence following treatment with the epidermal growth factor receptor inhibitor cetuximab: a single institution retrospective analysis 146
Discrepancy of p16 immunohistochemical expression and HPV RNA in penile cancer. A multiplex in situ hybridization/immunohistochemistry approach study 146
Adjuvant Treatment in Pancreatic Cancer: Shaping the Future of the Curative Setting 146
Immunotherapy in Penile Squamous Cell Carcinoma: Present or Future? Multi-Target Analysis of Programmed Cell Death Ligand 1 Expression and Microsatellite Instability 144
Sequence-dependent antiproliferative effects of cytotoxic drugs and epidermal growth factor receptor inhibitors 144
A rare case of extraovarian primary peritoneal carcinoma in a 72 year-old woman 144
Is complete mesocolic excision with central vascular ligation safe and effective in the surgical treatment of right-sided colon cancers ? A prospective study. 144
Clinical efficacy of sequential treatments in KRASG12C-mutant metastatic colorectal cancer: findings from a real-life multicenter Italian study (CRC-KR GOIM) 143
Identification of Tissue miRNA Signatures for Pancreatic Ductal Adenocarcinoma 143
Addition of either irinotecan or methotrexate to bolus 5-fluorouracil and high-dose folinic acid every 2 weeks in advanced colorectal carcinoma: A randomised study by the Southern Italy Cooperative Oncology Group 143
Three dimensional primary cultures for selecting human breast cancers that are sensitive to the anti-tumor activity of ipatasertib or taselisib in combination with anti-microtubule cytotoxic drugs 142
Comprehensive genomic profiling by liquid biopsy captures tumor heterogeneity and identifies cancer vulnerabilities in patients with RAS/BRAF wild-type metastatic colorectal cancer in the CAPRI 2-GOIM trial 141
A meta-analysis of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 discordance between primary breast cancer and metastases. 141
HER2-Low Status Does Not Affect Survival Outcomes of Patients with Metastatic Breast Cancer (MBC) Undergoing First-Line Treatment with Endocrine Therapy plus Palbociclib: Results of a Multicenter, Retrospective Cohort Study 140
Anthracycline-induced cardiotoxicity: monitoring and prevention of the lesion 140
Farmacogenomica e cancro colorettale 139
Hepatoid carcinoma colliding with a liposarcoma of the left colon serosa presenting as an abdominal mass 139
Analysis of recovery time indexes in 5-fluorouracil-treated cancer patients 139
Atypycal presentation of Merkel cell carcinoma positive to polyomavirus DNA detection: experience from a single center 138
The over-the-scope-clip (OTSC) system is effective in the treatment of chronic esophago-jejunal anastomotic leakage 138
Triple-Negative Breast Cancers: Systematic Review of the Literature on Molecular and Clinical Features with a Focus on Treatment with Innovative Drugs 137
Panitumumab Plus Trifluridine-Tipiracil as Anti-Epidermal Growth Factor Receptor Rechallenge Therapy for Refractory RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial 136
Assessment of the DNA Mismatch Repair System Is Crucial in Colorectal Cancers Necessitating Adjuvant Treatment: A Propensity Score-Matched and Win Ratio Analysis 136
Complete response to preoperative chemoradiation and survival in esophageal cancer : a pooled analysis of three singe-institution phase II trials. 136
Adjuvant chemotherapy of gastric cancer: which regimen? 135
Pattern of recurrence and overall survival in esophagogastric cancer after perioperative FLOT and clinical outcomes in MSI-H population: the PROSECCO Study 134
Serum interleukin-10 is an independent prognostic factor in advanced solid tumors 134
p27 downregulation and metallothionein overexpression in gastric cancer patients are associated with a poor survival rate 134
Increased circulating levels of vascular endothelial growth factor C can predict outcome in resectable gastric cancer patients 134
Synergistic Antitumor Activity of Sorafenib in Combination with Epidermal Growth Factor Receptor Inhibitors in Colorectal and Lung Cancer Cells 133
Panitumumab plus trifluridine/tipiracil as anti‐EGFR rechallenge therapy in patients with refractory RAS wild‐type metastatic colorectal cancer: Overall survival and subgroup analysis of the randomized phase II VELO trial 132
Cardiotossicità da antracicline: attualità e prospettive 132
TRATTAMENTO MULTIMODALE DEL CA ESOFAGEO. NOSTRA ESPERIENZA 132
Immune-Based Therapy in Triple-Negative Breast Cancer: From Molecular Biology to Clinical Practice 131
Implementation of BRCA mutations testing in formalin-fixed paraffin-embedded (FFPE) samples of different cancer types 131
The lymph node ratio is a powerful prognostic factor of node-positive colon cancers undergoing potentially curative surgery. 131
Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies 131
PROSPETTIVE DELLA TERAPIA NEOADIUVANTE NEL CANCRO ESOFAGEO AVANZATO 131
Presence of tumor deposits is a strong indicator of poor outcome in patients with stage III colorectal cancers undergoing radical surgery 130
Vertebral carcinomatosis eleven years after advanced gastric cancer resection: A case report. 130
PERSPECTIVES OF THE NEOADJUANT THERAPY IN ADVANCED ESOPHAGEAL CARCINOMA 130
Elevated serum levels of interleukin-8 in advanced non-small cell lung cancer patients: Relationship with prognosis 130
TRASTUZUMAB RESISTANCE IN BREAST CANCER 130
Perioperative Treatment in Resectable Gastric Cancer: Current Perspectives and Future Directions 130
Integrated therapy in localized gastric cancer: targeted and tailored approach. 129
Il linfoma primitivo della parotide: una localizzazione infrequente 129
Totale 15.374
Salva come PNG Salva come JPEG
Categoria #
all - tutte 116.076
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 116.076
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.319 0 10 16 24 528 8 29 48 51 61 125 419
2022/20233.327 429 61 45 262 363 256 15 194 1.587 14 55 46
2023/20241.307 107 36 59 117 444 166 11 31 16 19 95 206
2024/20253.993 37 109 38 110 618 512 491 367 567 549 306 289
2025/202617.073 593 826 815 843 1.354 9.303 792 931 722 435 233 226
2026/2027573 235 338 0 0 0 0 0 0 0 0 0 0
Totale 32.802